Cardinal Health CAH Pharmaceutical and Specialty Solutions — Total Costs & Expenses

Similar metrics at other companies

BAXPharmaceuticals — Selling, general and administrative expenses

$102M-1.0%

NVSTSpecialty Products & Technologies — Expenses

$411.3M+13.4%

PRGOSpecialty Care — Total Operating Expenses

$58.9M-21.4%

CLMTSpecialty Products And Solutions — Segment Reporting Other Segment Expenses Amount

$9.2M+5.7%

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

DDDHealthcare Solutions — Total cost of sales

$27.84M+10.1%

Questions, answered.

What is Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses?

Cardinal Health (CAH) reported pharmaceutical and specialty solutions — total costs & expenses of $55.33B in Q1 2026.

How has Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses changed year-over-year?

Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses increased by 11.2% year-over-year, from $49.77B to $55.33B.

What is the long-term trend for Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses?

Over 2 years (2023 to 2025), Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses has grown at a 4.1% compound annual growth rate (CAGR), from $186.93B to $202.39B.

What does pharmaceutical and specialty solutions — total costs & expenses mean?

The aggregate of all costs, including cost of products sold and distribution, selling, general, and administrative expenses, incurred by the Pharmaceutical and Specialty Solutions segment. This provides a comprehensive view of the total expenditure required to maintain segment operations. It is used to derive the segment's operating earnings.